PREVENT HPV -Related Cancers Trial

About This Study

This study will serve as one of the first to develop and test the effectiveness of strategies to promote HPV vaccination among diverse rural parents and caregivers of children ages 9-17 years in the Mountain West. Once implemented into practice, our intervention could significantly reduce disparities in the burden of HPV-associated cancers among rural populations in the United States. The proposed study will assess the effectiveness of clinic-based outreach to increase vaccination rates for HPV at four community clinics in rural counties in Washington. The proposed study includes the following a randomized controlled trial (RCT) that will assign adult parent/caregiver participants to a timeline for receiving intervention. This study will develop best practices, implementation guides, and dissemination of findings for other clinics to implement the program on a broader scale.

What's Involved

Conditions Studied

Study Locations

Eligibility

Inclusion Criteria:

* Parents/Caregivers (P/C) of children/adolescents (C/A) ages 9-17 years of age (i.e., age-eligible for HPV vaccination);
* P/C with active clinic patients (i.e., have been seen in the clinic in the last 12 months); and
* P/C who speak either English or Spanish.

Exclusion Criteria:

* P/C of C/A with previous excluding HPV vaccination history (e.g., completed vaccination, or not due);
* P/C of C/A with clinical conditions that influence the CDC HPV vaccination recommendations (e.g., pregnancy);
* P/C of C/A with other factors that would influence CDC HPV recommendations; and
* P/C that does not speak Spanish or English.